Indivior PLC
Indivior PLC (INVVY) Financial Performance & Income Statement Overview
Review Indivior PLC (INVVY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Indivior PLC (INVVY) Income Statement & Financial Overview
Analyze Indivior PLC’s INVVY earnings with segmented quarterly and yearly financial statement figures.
Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $307.00M | $299.61M | $282.74M | $300.65M |
Cost of Revenue | $69.00M | $116.24M | $52.76M | $55.41M |
Gross Profit | $238.00M | $183.37M | $229.97M | $245.24M |
Gross Profit Ratio | $0.78 | $0.61 | $0.81 | $0.82 |
R&D Expenses | $22.63M | $27.05M | $27.88M | $30.78M |
SG&A Expenses | $208.00M | $121.25M | $135.39M | $152.89M |
Operating Expenses | $234.00M | $148.30M | $163.27M | $183.67M |
Total Costs & Expenses | $303.00M | $264.54M | $216.03M | $239.08M |
Interest Income | $5.00M | $6.00M | $6.00M | $10.00M |
Interest Expense | $10.00M | $9.00M | $8.00M | $8.00M |
Depreciation & Amortization | -$10.00M | $25.05M | $8.96M | $9.23M |
EBITDA | $9.00M | -$101.21M | $80.64M | $70.80M |
EBITDA Ratio | $0.03 | $0.20 | $0.27 | $0.24 |
Operating Income | $4.00M | $35.07M | $66.70M | $61.57M |
Operating Income Ratio | $0.01 | $0.12 | $0.24 | $0.20 |
Other Income/Expenses (Net) | -$5.00M | -$3.00M | -$2.00M | $1.59M |
Income Before Tax | -$1.00M | -$135.27M | $62.72M | $62.59M |
Income Before Tax Ratio | -$0.003 | -$0.45 | $0.22 | $0.21 |
Income Tax Expense | -$5.00M | -$28.06M | $15.93M | $7.18M |
Net Income | $4.00M | -$107.22M | $47.00M | $54.00M |
Net Income Ratio | $0.01 | -$0.36 | $0.17 | $0.18 |
EPS | $0.03 | -$0.80 | $0.34 | $0.40 |
Diluted EPS | $0.03 | -$0.80 | $0.34 | $0.39 |
Weighted Avg Shares Outstanding | $132.10M | $134.85M | $135.74M | $137.32M |
Weighted Avg Shares Outstanding (Diluted) | $133.55M | $134.85M | $138.71M | $141.95M |
The company's financials show resilient growth, with revenue advancing from $300.65M in Q4 2023 to $307.00M in Q3 2024. Gross profit remained healthy with margins at 78% in Q3 2024 compared to 82% in Q4 2023. Operating income hit $4.00M last quarter, sustaining a consistent 1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $9.00M. Net income rose to $4.00M, while earnings per share reached $0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan